feed,title,long_url,short_url
Benzinga,Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients,https://benzinga.com/general/biotech/22/08/28633968/janssen-scores-conditional-approval-for-multiple-myeloma-treatment-in-pretreated-patients,https://bit.ly/3wxfHot
Benzinga,"Dynavax's Adjuvant Based COVID-19 Shot Shows Robust Immune Response, Safety In Younger Populations",https://benzinga.com/general/biotech/22/08/28633974/dynavaxs-adjuvant-based-covid-19-shot-shows-robust-immune-response-safety-in-younger-populations,https://bit.ly/3QRLTLg
